NCT06131411 (DIABETHIC) is a NA clinical trial of Health promotion in Diabetes Mellitus, Type 2, sponsored by Azienda Ospedaliero-Universitaria Careggi.

Who is sponsoring NCT06131411?

NCT06131411 is sponsored by Azienda Ospedaliero-Universitaria Careggi.

What drugs are being tested in NCT06131411?

Interventions in NCT06131411: Health promotion, Usual care.

What condition does NCT06131411 study?

NCT06131411 studies Diabetes Mellitus, Type 2.

Is NCT06131411 still recruiting?

NCT06131411 is currently completed. Last updated 29 January 2026.

Last reviewed 2026-01-29 · How we verify

NCT06131411: DIABETHIC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cardio-metabolic Diseases in Immigrants and Ethnic Minorities: From Epidemiology to New Prevention Strategies

Completed NA Last updated 29 January 2026

What this trial tests

NA trial testing Health promotion in Diabetes Mellitus, Type 2 in 202 participants. Completed in 31 October 2025.

Timeline

7 November 2023

Primary endpoint
31 October 2025

31 October 2025

Quick facts

Lead sponsor	Azienda Ospedaliero-Universitaria Careggi
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	202
Start date	7 November 2023
Primary completion	31 October 2025
Estimated completion	31 October 2025
Sites	4 locations across Italy

Drugs / interventions tested

Health promotion
Usual care

Conditions studied

Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →

Sponsor

Azienda Ospedaliero-Universitaria Careggi — full company profile →

Who can join

18 and older, any sex, with Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this clinical trial is to learn if intervention on health behavior can promote diabetes care and improve compliance to therapeutic protocols in ethnic minorities with type 2 diabetes. To answer this question, researchers will compare the effectiveness of co-created, culture-sensitive intervention to that of a usual-care approach to promote diabetes care 12 months after enrollment in first-generation immigrants with type 2 diabetes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A randomized trial to evaluate a complex, co-created, culture-sensitive intervention to promote healthy lifestyles and compliance to therapy in immigrants with type 2 diabetes: A protocol of a multicenter Italian study.
Bonvicini L, Venturelli F, Bononi F, Balestra GL, et al · · 2025 · cited 1× · PMID 39992940 · DOI 10.1371/journal.pone.0317994

Verify or expand the search:

Other trials of Health promotion

Trials testing the same drug.

NCT06844786 — SCORE! ACTIVE Trial · NA · recruiting
NCT05898503 — Effects of Different Types of Exercise on Cognitive Function in Postmenopausal Hypertensive Women · NA · unknown
NCT02871752 — Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness Education · NA · completed

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting

Other Azienda Ospedaliero-Universitaria Careggi trials

Trials by the same sponsor.

NCT07296055 — Endobronchial Valve in Tubercular and NTM Pulmonary Cavities. · NA · not yet recruiting
NCT07289581 — Effect of Treatment With Butyric Acid in Anorexia Nervosa · NA · active not recruiting
NCT06978608 — Ultrasound and Somatosensory Median Nerve Evaluation in CRPS I · not yet recruiting
NCT07005882 — Hormonal Receptor (HR)-Positive HER2 Negative Breast Cancer Patients Treated With Preoperative ELacestrant and PULSAR Ra · Phase 2 · not yet recruiting
NCT06529601 — Comparison Between CAD/CAM and Conventional Mandibular Fixed Retainers. · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06131411 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliero-Universitaria Careggi
Last refreshed: 29 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06131411.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing